These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36940185)

  • 1. A systematic review of allergen immunotherapy, a successful therapy for canine atopic dermatitis and feline atopic skin syndrome.
    Mueller RS
    J Am Vet Med Assoc; 2023 Jun; 261(S1):S30-S35. PubMed ID: 36940185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Allergen Immunotherapy.
    Mueller RS
    Vet Clin North Am Small Anim Pract; 2019 Jan; 49(1):1-7. PubMed ID: 30227970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
    Mueller RS; Bettenay SV
    Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats.
    Trimmer AM; Griffin CE; Boord MJ; Rosenkrantz WS
    Vet Dermatol; 2005 Oct; 16(5):324-9. PubMed ID: 16238812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, double-blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs.
    Mueller RS; Zablotski Y; Baumann K; Boehm T; Kasper B; Klinger C; Monke M; Udraite-Vovk L; Weitzer T; Gedon NKY
    Vet Dermatol; 2023 Apr; 34(2):91-98. PubMed ID: 36424528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs.
    Mueller RS; Jensen-Jarolim E; Roth-Walter F; Marti E; Janda J; Seida AA; DeBoer D
    Allergy; 2018 Oct; 73(10):1989-1999. PubMed ID: 29675865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis.
    Hobi S; Mueller RS
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(3):167-73. PubMed ID: 24920143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine and feline atopic dermatitis: a review of the diagnostic options.
    Rees CA
    Clin Tech Small Anim Pract; 2001 Nov; 16(4):230-2. PubMed ID: 11793877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of rush immunotherapy in the management of canine atopic dermatitis-230 cases.
    Weitzer T; Mueller R
    Vet Dermatol; 2023 Oct; 34(5):385-392. PubMed ID: 37157908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of primary care practitioners' referral habits and recommendations of allergen-specific immunotherapy for canine and feline patients with atopic dermatitis.
    Flanagan S; Schick A; Lewis TP; Chu Tater K; Rishniw M
    Vet Dermatol; 2021 Apr; 32(2):106-e21. PubMed ID: 33275300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
    Plant JD; Neradilek MB
    BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.
    Timm K; Mueller RS; Nett-Mettler CS
    Vet Dermatol; 2018 Apr; 29(2):123-e49. PubMed ID: 29327474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
    Fischer NM; Rostaher A; Favrot C
    Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.
    van Amersfort K; Vernooij JCM; van der Lee A
    Vet Dermatol; 2023 Oct; 34(5):373-384. PubMed ID: 37186491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy.
    Martini F; Rostaher A; Favrot C; Fischer N
    Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
    Fujimura M; Ishimaru H
    Pol J Vet Sci; 2016; 19(1):3-6. PubMed ID: 27096781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis.
    Schnabl B; Bettenay SV; Dow K; Mueller RS
    Vet Rec; 2006 Jan; 158(3):81-5. PubMed ID: 16428661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
    Griffin CE; Hillier A
    Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.